Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Total 13F shares
-
297,231,224
-
Share change
-
+6,193,326
-
Total reported value
-
$3,295,863,806
-
Put/Call ratio
-
156%
-
Price per share
-
$11.09
-
Number of holders
-
219
-
Value change
-
+$67,134,100
-
Number of buys
-
122
-
Number of sells
-
80
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q1 2023
As of 31 Mar 2023,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
219 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
297,231,224 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., Redmile Group, LLC, MORGAN STANLEY, JPMORGAN CHASE & CO, JANUS HENDERSON GROUP PLC, STATE STREET CORP, and Palo Alto Investors LP.
This page lists
222
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.